Gaziano, J., Brotons, C., Coppolecchia, R., Cricelli, C., Darius, H., Gorelick, P., . . . Committee, A. (2018). Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): A randomised, double-blind, placebo-controlled trial. Elsevier.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Gaziano, J., et al. Use of Aspirin to Reduce Risk of Initial Vascular Events in Patients at Moderate Risk of Cardiovascular Disease (ARRIVE): A Randomised, Double-blind, Placebo-controlled Trial. Elsevier, 2018.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Gaziano, J., et al. Use of Aspirin to Reduce Risk of Initial Vascular Events in Patients at Moderate Risk of Cardiovascular Disease (ARRIVE): A Randomised, Double-blind, Placebo-controlled Trial. Elsevier, 2018.